Please assess the completion status of the following clinical trial:

Trial Title: Study of Fish Oil to Reduce ALT Levels in Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* BMI (kg/m2) at or above the 95th percentile for age and gender~* Weight below 400 pounds (less than 182 kilograms)~* Persistent elevation of ALT (41-90 UI/L at study screening)~* Presence of hepatic steatosis on abdominal CT-scan~* Able to give informed consent/assent~Exclusion Criteria:~* Type 2 diabetes mellitus~* Prior drug treatment for diabetes, insulin insensitivity, or weight loss medications six months before screening~* Use of prescription strength glucocorticoids within three months before screening~* History of syndrome or medical disorder associated with significant obesity~* Participation in a weight loss program within six months of screening resulting in 5% or more weight loss~* History of weight loss surgery~* Alcohol use more than twice weekly or more than 3 alcohol containing beverages within a 24-hour period in the past six months~* Known or suspected bleeding condition~* History of liver disease including prior liver biopsy with NASH type 2 or cirrhosis~* Former or present positive blood tests for Infectious hepatitis B or C, autoimmune hepatitis, Wilson disease, Alpha-1 anti-trypsin deficiency, Iron storage disease, or high TSH~* History of past or current pregnancy~* Use of illegal/illicit drugs~* Other conditions contraindicated or cause for caution in the use of fish oil~* Unable to comply with the protocol~* Any other serious disease determined by the study gastroenterologists and physician nutrition specialist as potential study risk for the patient

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Fish oil (Type: EXPERIMENTAL): Omega-3-acid ethyl esters in the form of fish oil capsules with ram up from 1g to 4 g/day (capsules 1g)
- Placebo (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).